Medindia

X

Complete Genomics Announces Its First Public Presentation at the 7th Annual BIO Investor Forum

Thursday, October 23, 2008 General News J E 4
Advertisement
MOUNTAIN VIEW, Calif., Oct. 22 Complete Genomics Inc., anewly launched, third-generation human genome sequencing company, todayannounced the company's presentation at the 7th Annual BIO Investor Forum,which will be held in San Francisco, Oct. 29-31, 2008.

Dr. Clifford Reid, chairman, president and chief executive officer ofComplete Genomics, will present on Wednesday, Oct. 29, at 2:45 p.m. in theMarina Room of the Palace Hotel, located at 2 New Montgomery Street indowntown San Francisco. He will discuss how Complete Genomics' scalableservice model and proprietary technology advances will allow the company tointroduce its sequencing service in Q2 2009 at a cost of $5,000 per genome.

About Complete Genomics

Founded in 2006, Complete Genomics is a California company that hasdeveloped a novel approach to sequencing human DNA. Complete Genomics plans tocombine its proprietary third-generation DNA sequencing technology and itshigh-performance computing capabilities to create a human genome sequencingservice that will deliver low-cost, high-quality data on an unprecedentedscale. The company is currently building the world's largest human genomesequencing center. This development will allow pharmaceutical andbiotechnology customers, for the first time, to conduct large-scale humangenome studies that will help identify the genetic underpinnings of complexdiseases and drug responses. For additional information about the company,please visit http://www.completegenomics.com.

SOURCE Complete Genomics Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Tree.com CFO Goes to Jail to Combat Muscular Dystr...
S
U.S. Food and Drug Administration (FDA) Approves P...